Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ANGIODYNAMICS INC Director's Dealing 2010

Apr 9, 2010

32939_dirs_2010-04-09_145e1cb5-6631-4a0b-a7d3-f8e2a0b843ee.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2010-04-07

Reporting Person: LaPorte Steve (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-04-07 Common Stock P 500 $15.52 Acquired 7013 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Non-Qualified Stock Option (right to buy) $13.29 2016-09-04 Common Stock (12000) 12000 Direct
Non-Qualified Stock Option (right to buy) $15.27 2015-08-06 Common Stock (6000) 6000 Direct
Non-Qualified Stock Option (right to buy) $16.53 2014-05-01 Common Stock (25000) 25000 Direct
Non-Qualified Stock Option (right to buy) $17.76 2017-07-27 Common Stock (6000) 6000 Direct
Non-Qualified Stock Option (right to buy) $20.15 2015-09-29 Common Stock (6027) 6027 Direct
Non-Qualified Stock Option (right to buy) $22.06 2016-06-07 Common Stock (4434) 4434 Direct

Footnotes

F1: Options for 33 1/3 of the shares are each exercisable on 8/6/09, 8/6/10, and 8/6/11 respectively

F2: Options for 33 1/3% of the shares are each exercisable on 5/1/08, 5/1/09, 5/1/10, respectively.

F3: Options for 25% of the total number of shares each become exercisable on 7/27/08, 7/27/09, 7/27/10, and 7/27/11.

F4: Options to acquire .1722 shares of AngioDynamics common stock were received in exchange for options to acquire 1 share of
RITA Medical Systems, Inc., in conjunction with AngioDynamics acquisition of RITA Medical on January 29, 2007. Upon
exercise, the option holder is also entitled to $.515 per original RITA share, or $2.99 per AngioDynamics share exercised.